← Back to Search

Telmisartan (80 mg) for Coronavirus (INTEL Trial)

Phase 2
Waitlist Available
Led By Cecilia M Shikuma
Research Sponsored by University of Hawaii
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up on day 4 and day 21 of study
Awards & highlights

INTEL Trial Summary

This study is evaluating whether a drug called telmisartan can help people with COVID-19.

Eligible Conditions
  • Coronavirus

INTEL Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~on day 4 and day 21 of study
This trial's timeline: 3 weeks for screening, Varies for treatment, and on day 4 and day 21 of study for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Duration of hospitalization
Secondary outcome measures
Clinical severity of disease
Duration of mechanical ventilation
Duration of supplemental oxygen
+2 more
Other outcome measures
Angiotensin 1-7 /Angiotensin II ratio

INTEL Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Telmisartan (80 mg)Active Control1 Intervention
Telmisartan 80 mg (given as two 40 mg encapsulated tablets) given orally each day x 21 days
Group II: PlaceboPlacebo Group1 Intervention
Two placebo capsules given orally each day x 21 days

Find a Location

Who is running the clinical trial?

University of HawaiiLead Sponsor
115 Previous Clinical Trials
54,665 Total Patients Enrolled
Queens Medical CenterUNKNOWN
Cecilia M ShikumaPrincipal InvestigatorUniversity of Hawaii at Manoa John A Burns School of Medicine

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
INvestigating TELmisartin Study
2021. "INvestigating TELmisartin Study". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04715763.
~7 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top